Worldwide has been chosen as one of Pharma Tech Outlook’s Top 10 Bioanalytical Services Companies of 2019. Read more in the following cover story.

Worldwide has implemented and completed over 40 studies with Foundry Health’s eSource platform, ClinSpark. Read more about the platform in the following article from Outsourcing-Pharma.

In the following article in the Journal for Clinical Studies, Aman Khera, Barry J. Dussault, and Henry J. Riordan write about regulatory and operational considerations with the recent global interest in developing therapies related to cannabis.

In the following article by the Triangle Business Journal, Peter Benton is interviewed about Worldwide’s rapid growth, global expansion, and plans for the future.

In the following article by the Journal for Clinical Studies, Travis Caudill writes how the shift from large-scale, global clinical trials to focused orphan indication studies is impacting site feasibility.

In the following article by the Journal for Clinical Studies, Henry J. Riordan, Michael Murphy, Eric D Perakslis, and Sam Roosz discuss how to use large data sets and extended trial observations to close the Alzheimer’s real-world evidence gap.